Home

bâton oasis ciment jean paul clozel Sœur Le commandant battre en retraite

38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images

Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook
Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook

Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel  verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»

Idorsia insomnia drug starts FDA review as founder Clozel's second act  proceeds | Reuters
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters

Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip

Jean-Paul Clozel
Jean-Paul Clozel

Jean-Paul Clozel
Jean-Paul Clozel

Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile

J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg
J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg

Jean-Paul Clozel
Jean-Paul Clozel

Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg

Jean-Paul Clozel, CEO Actelion - YouTube
Jean-Paul Clozel, CEO Actelion - YouTube

J&J snaps up Idorsia's resistant hypertension candidate, paying $230M |  Fierce Biotech
J&J snaps up Idorsia's resistant hypertension candidate, paying $230M | Fierce Biotech

PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia

Jean-Paul Clozel – Billionaire | Phnom Penh HR
Jean-Paul Clozel – Billionaire | Phnom Penh HR

38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images

Idorsia, a small company with a big portfolio says Martine Clozel
Idorsia, a small company with a big portfolio says Martine Clozel

Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels  (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news  conference at Actelion headquarters in Allschwil, Switzerland January 26,  2017. REUTERS/Arnd
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd

Idorsia will take three to four years to reach profitability, CEO says
Idorsia will take three to four years to reach profitability, CEO says

Medical couple and butcher's boy win big from Actelion sale | Reuters
Medical couple and butcher's boy win big from Actelion sale | Reuters

Was plant das Ehepaar Clozel? | NZZ
Was plant das Ehepaar Clozel? | NZZ

Jean-Paul Clozel et Martine Clozel - Les 500 plus grandes fortunes de  France - Challenges
Jean-Paul Clozel et Martine Clozel - Les 500 plus grandes fortunes de France - Challenges

PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland
PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland

From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel &  Martine Clozel
From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel & Martine Clozel